Loading
Healthequity, Inc. Stock: price and insider trades · United States
1 insider bought €11k of shares over the last 90 days, the latest by Rajasekar Sunil, filed 19 Oct 2026.
Insider Decl.
1,189
Thresholds
n/a
Buy Volume
€4M
10 ops. · all time
Sell Volume
€625M
482 ops. · all time
Who traded when
BuySaleKessler Jon9 sales
Selander Robert W7 sales
Delano Ladd6 sales
Michael Henry Fiore6 sales
Rosner Elimelech4 sales
Sunil Rajasekar2 buys2 sales
+6 other insiders
Since the insiders bought
- +53.1%Entry US$40.43 · Close at T+365 US$61.89
- +51.4%Entry US$40.07 · Close at T+365 US$60.67
- +54.2%Entry US$40.85 · Close at T+365 US$63.00
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Analyst consensus: bullish or bearish?
Analysts rate Healthequity, Inc. Strong Buy (bullish), based on 15 analysts. Average price target: US$120.67.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 9,298 of 26,246 companies
58.8
score / 100
Value46
Quality71
FCF yld5.0%
Earn yld2.7%
EV/EBITDA18.6x
ROE11%
Gross mgn70%
Net mgn16%
Debt/EBITDA2.0x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2026FY ended January 2026 · cache
US$97.88
Analyst consensus
15 analystsStrong buy
US$108.00Target US$120.67(+23%)US$142.00
Income statement
RevenueUS$1.3B
Gross profitUS$913.1M70% margin
EBITDAUS$489.2M37% margin
Net incomeUS$215.2M17.4% margin
Valuation
PER (trailing)35.5x
PER (forward)17.8x
P/Book4.1x
Beta0.24
Balance sheet & cash
Market capUS$8.1B
Total debtUS$1B
Free Cash FlowUS$408.3M
Debt / Equity49%
Profitability & ownership
ROE11.4%
ROA6.7%
% insiders2.2%
% institutions110.1%
Last declaration on 19 October 2026
Declarations1,189 total
108 shares@ US$90.330.0001% mcap39.5% of flowCommon StockSEC:0001934884-26-000007:3
Canonical exit: 13 Jan 2027 (T+90)
108 shares@ US$105.600.0001% mcap44.4% of flowCommon StockSEC:0001934884-26-000007:2
23 shares@ US$82.817.4% of flowCommon StockSEC:0001934884-26-000007:0
23 shares@ US$95.068.7% of flowCommon StockSEC:0001934884-26-000007:1
Canonical exit: 6 Oct 2026 (T+90)
1,095 shares@ US$91.15530.0014% mcap49.1% of flowCommon StockSEC144:0001614838-26-000022
1,230 shares@ US$91.15530.0015% mcap49.2% of flowCommon StockSEC144:0001715537-26-000016
2,032 shares@ US$91.15530.0025% mcap49.2% of flowCommon StockSEC144:0002016116-26-000022
662 shares@ US$91.15530.0008% mcap22.5% of flowCommon StockSEC144:0002076763-26-000009
2,822 shares@ US$91.15530.0035% mcap49.2% of flowCommon StockSEC144:0001638683-26-000018
1,080 shares@ US$91.15530.0013% mcap49.2% of flowCommon StockSEC144:0001683056-26-000022
2,822 shares@ US$91.15530.0035% mcap10.7% of flowCommon StockSEC:0001638683-26-000020:0
1,230 shares@ US$91.15530.0015% mcap6.5% of flowCommon StockSEC:0001715537-26-000018:0
1,080 shares@ US$91.15530.0013% mcap2.1% of flowCommon StockSEC:0001683056-26-000024:0
2,032 shares@ US$91.15530.0025% mcap8.2% of flowCommon StockSEC:0002016116-26-000024:0
1,095 shares@ US$91.15530.0014% mcap1.9% of flowCommon StockSEC:0001614838-26-000024:0
662 shares@ US$91.15530.0008% mcap22.5% of flowCommon StockSEC:0002076763-26-000011:0
1,500 shares0Common StockSEC:0001614838-26-000020:0
7,632 shares@ US$32.500.0032% mcap15.9% of flowCommon StockSEC:0001163402-26-000004:0
6,300 shares@ US$104.47180.0086% mcap42.1% of flowCommon StockSEC:0001163402-26-000004:1
1,332 shares@ US$105.25570.0018% mcap9.0% of flowCommon StockSEC:0001163402-26-000004:2
7,632 shares@ US$105.400.010% mcap100.0% of flowCommonSEC144:0001950047-26-008667
2,354 shares@ US$95.000.0030% mcap10.5% of flowCommon StockSEC:0002016116-26-000020:0
2,270 shares@ US$93.06610.0028% mcap100.0% of flowCommon StockSEC144:0002076763-26-000004
2,270 shares@ US$93.06610.0028% mcap100.0% of flowCommon StockSEC:0002076763-26-000006:0
2,045 shares@ US$95.08310.0026% mcap100.0% of flowCommon StockSEC144:0002016116-26-000016
25 of 1189 declarations
About Healthequity, Inc.
At HealthEquity, Inc., Berkley Capital, LLC, filed as 10% Owner, sold EUR 72,635,843 on October 25, 2016 and EUR 43,706,197 on January 19, 2017, the two largest sales in the record. Frank Medici (Director) signed one for EUR 14,888,707 on July 12, 2017. The 486 sales total EUR 632.3 million, with a median of EUR 315,567.
Purchases are rare: 10 worth EUR 3.9 million (median EUR 492,938), or 2% of open-market trades. Stuart B. Parker (Director) bought EUR 943,539 on December 9, 2021. On July 12, 2019, 4 filers bought EUR 2,168,428, including Adrian T. Dillon (Director) and Jon Kessler (President and CEO), EUR 542,107 each. Across the full history, 6 purchase filings are classed as clustered.
Read moreShow less
Stephen Neeleman (FOUNDER AND VICE CHAIRMAN) signs 182 of the 1,187 filings, 84 of them sales and one a purchase; Jon Kessler 153, with 80 sales; Darcy G. Mott (Executive VP and CFO) 119. Yearly volume peaks at 219 in 2017 and falls to 60 in 2019. There are 434 grants and 202 option exercises. The US healthcare and pharma company is worth USD 7.70 billion, with 2.2% held by insiders. Last twelve months: 80 filings, 2 purchases, 10 sales.
